LifeMD, Inc. 10-Q

ITEM 5. OTHER INFORMATION None. ITEM 6. EXHIBITS Incorporated by Reference Exhibit Number Exhibit Description Form Exhibit Filing Date/Period End Date Filed Herewith 10.1 Form of Convertible Redeemable Promissory Note 8-K 4.1 5/27/2020 10.2 Alpha 2019 Note Repayment and Warrant Amendment 10-Q 10.3 5/19/2020 10.3 Alpha 2018 Warrant Amendment. 10-Q 10.4 5/19/2020 10.4 Brio 2019 Note Repayment and Warrant Amendment 10-Q 10.5 5/19/2020 10.5 Brio 2018 Warrant Amendment 10-Q 10.6 5/19/2020 10.6 Form of Purchase Agreement 10-Q 10.7 5/19/2020 10.7 Consulting Agreement by and between the Company and Auxo Technology Labs. 10-Q 10.8 5/19/2020 31.1* Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer. X 31.2* Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer. X 32.1** Section 1350 Certification of Chief Executive Officer. X 32.2** Section 1350 Certification of Chief Financial Officer. X 101.INS* XBRL Instance Document X 101.SCH* XBRL Taxonomy Extension Schema Document X 101.CAL* XBRL Taxonomy Extension Calculation Linkbase Document X 101.DEF* XBRL Taxonomy Extension Definition Linkbase Document X 101.LAB* XBRL Taxonomy Extension Label Linkbase Document X 101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document X ** In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed. 34 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CONVERSION LABS, INC. By: /s/ Justin Schreiber Justin Schreiber Chief Executive Officer and Chairman of the Board (Principal Executive Officer) Date: August 14, 2020 By: /s/ Juan Manuel Piñeiro Dagnery Juan Manuel Piñeiro Dagnery Chief Financial Officer (Principal Financial Officer) Date: August 14, 2020 35